Alcohol and Antidepressants. The Interaction, the Risk, and What Treatment Actually Does

Alcohol and antidepressant co-use is the pattern that Jintara encounters most often at admission. Most clients who arrive with an alcohol problem are already being treated for depression, anxiety, or trauma, and many are on an antidepressant the day they walk in. About 99 per cent of clients arrive with what is technically a dual diagnosis, even when they have not been told to call it that. Many are self-medicating an underlying mental health condition with alcohol.

The picture looks like this. A doctor at home prescribed an SSRI or SNRI for depression. The drinking did not stop. The antidepressant is still being taken, the alcohol is still being drunk, and neither one is working as it should. That is the problem this page addresses.

Alcohol disrupts antidepressant efficacy through four concurrent mechanisms that compound each other over time. Antidepressants in the SSRI and SNRI families work by changing how serotonin and noradrenaline behave in the brain. They take three to six weeks to reach therapeutic effect and need a relatively stable neurochemical environment to do that work.

First, alcohol is a central nervous system depressant. When stacked on an antidepressant, the combined depressant load increases sedation, slows reaction time, and worsens mood the next day, even when the antidepressant alone would have lifted it. Second, alcohol reduces antidepressant efficacy directly. The neurochemical effect of regular drinking pushes against the slow, steady change the antidepressant is trying to produce. Many clients describe months of 'the medication is not doing anything.' Often the medication is doing exactly what it should; the alcohol is undoing it.

Third, there is a rare but serious risk of serotonin syndrome, covered in the next section. Fourth, alcohol and most antidepressants share liver metabolism pathways, creating a dose-unpredictability problem covered in the liver metabolism section below. NIAAA's Core Resource on Alcohol characterises alcohol use disorder as a condition that disrupts neurochemical balance across multiple systems simultaneously.

Serotonin syndrome happens when there is too much serotonin activity in the central nervous system. With antidepressants alone, the risk is low at therapeutic doses. The risk rises when serotonin-active substances are stacked: SSRIs combined with SNRIs, with tramadol, with St John's Wort, or with heavy alcohol use, particularly binge drinking on top of daily antidepressant use.

Warning signs to recognise:

Alcohol is metabolised primarily in the liver. So are most antidepressants, including the common SSRI and SNRI families. They use overlapping enzyme pathways. When both substances are present in the body together, the liver is competing for the same resources to clear both.

The practical consequences: antidepressant levels in the blood become less predictable, with some doses behaving higher than expected and some lower; side effects from the antidepressant become harder to read because alcohol produces similar symptoms; and long-term liver function suffers, particularly in clients with several years of heavy drinking already present.

At Jintara, a full medical workup runs on day two at the clinic's expense. This includes liver function tests as standard. Results are shared with the psychiatrist for any dose adjustment decisions.

There is a clinical pattern Jintara sees repeatedly. A client arrives convinced that nothing will help, that the antidepressant has failed, and that the depression is permanent. Two to three weeks into a sober, structured environment, they report feeling markedly better.

What is happening neurochemically: alcohol disrupts sleep, dehydrates the brain, depresses serotonin and noradrenaline activity, and damages the very systems an antidepressant is trying to support. When alcohol stops, the brain begins the slow process of returning to baseline. Sleep architecture improves. Hydration restores. Mood lifts. The antidepressant, freed from chemical opposition, gets the runway to actually work.

This is not a guarantee. Some clients carry an underlying depression that long predates the drinking, and that depression remains after medical detox. For those clients, the antidepressant continues, the dose may be reviewed by Jintara's psychiatrist, and the therapeutic work focuses on the underlying condition. NIDA's research on addiction and the brain describes the neurological recovery process that begins with abstinence and continues over months.

Do not stop your antidepressant on your own when you start detox. Do not skip doses without your prescribing doctor and a treating psychiatrist in the loop. Sudden discontinuation of an SSRI or SNRI can produce its own withdrawal syndrome: dizziness, brain zaps, nausea, agitation, and a sudden drop in mood. Adding that to alcohol withdrawal makes a difficult detox harder and less safe.

What happens at Jintara instead. You see the psychiatrist within the first 24 to 48 hours. The psychiatrist reviews your existing antidepressant, dose, prescriber, and the reason it was started. Decisions about continuing, adjusting, or tapering are made clinically, with you, in writing. The clinical team and registered nurses coordinate the schedule so the antidepressant is taken consistently, not missed during the disorientation of early detox.

Clinical Institute Withdrawal Assessment for Alcohol, Revised (CIWA-Ar) scoring runs in parallel for the alcohol withdrawal. CIWA-Ar tracks withdrawal severity in real time and guides the benzodiazepine taper protocol when one is needed. The two protocols, antidepressant continuity and CIWA-Ar-guided alcohol withdrawal management, run concurrently under the same clinical team.

When other substances are also involved, such as a benzodiazepine for sleep or an opioid painkiller, each changes the clinical risk meaningfully. Benzodiazepines combined with alcohol involve overlapping seizure risk in different time windows. The alcohol and opioid combination adds respiratory depression cascade, making it the most lethal mix in everyday substance use. If your situation involves more than alcohol plus an antidepressant, say so on the admissions call. The clinical plan is built around the full picture.

A client on antidepressants who is still drinking has three problems running at once: alcohol dependency; untreated or undertreated depression; and the link between them, where the drinking is a self-medicating response to feelings the antidepressant alone has not been able to lift.

A program that only treats the alcohol leaves the depression intact. A program that only treats the depression leaves the drinking intact. The dependency relapses, the depression returns, and you are back where you started. Jintara works all three at the same time.

Jintara's position on medication is what Denise calls 'skills over pills': continue what you came in on, treat any medical need that arises during your stay, and work hard to ensure you do not leave on more medication than you arrived with. Jintara does not prescribe naltrexone, acamprosate, disulfiram, or other oral relapse prevention medications post-detox. Relapse prevention is therapy-led, structured around the underlying mental health condition.

Once the toxins clear, the work moves into the mental health side. As Darren describes it, 'It really starts off with focus on the addiction, and as the withdrawals slip away and the toxins remove out the body, we move more into the mental health component of the treatment.' Individual sessions, group therapy, and where appropriate EMDR therapy for trauma that underlies the addiction all run under the same clinical roof.

The timeline below is the typical clinical trajectory for a client arriving with alcohol use disorder and an active antidepressant prescription.